| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3646MU2013IN2013MU03646A (en) | 2013-11-20 | 2014-11-19 | |
| US15/037,822US20160287614A1 (en) | 2013-11-20 | 2014-11-19 | Stable Pharmaceutical Formulation(s) of Tetracycline Antibiotic |
| PCT/IB2014/066152WO2015075640A1 (en) | 2013-11-20 | 2014-11-19 | Stable pharmaceutical formulation(s) of tetracycline antibiotic |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3646MU2013IN2013MU03646A (en) | 2013-11-20 | 2014-11-19 |
| Publication Number | Publication Date |
|---|---|
| IN2013MU03646Atrue IN2013MU03646A (en) | 2015-07-31 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3646MU2013IN2013MU03646A (en) | 2013-11-20 | 2014-11-19 |
| Country | Link |
|---|---|
| US (1) | US20160287614A1 (en) |
| IN (1) | IN2013MU03646A (en) |
| WO (1) | WO2015075640A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060140984A1 (en) | 2002-10-25 | 2006-06-29 | Foamix Ltd. | Cosmetic and pharmaceutical foam |
| IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
| US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
| US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
| US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
| US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
| WO2009090495A2 (en) | 2007-12-07 | 2009-07-23 | Foamix Ltd. | Oil and liquid silicone foamable carriers and formulations |
| WO2010125470A2 (en) | 2009-04-28 | 2010-11-04 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| WO2011013008A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| CA2769625C (en) | 2009-07-29 | 2017-04-11 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| BR112012007473A2 (en) | 2009-10-02 | 2019-05-07 | Foamix Ltd | tetracycline topical compositions and methods of use |
| AU2016224863A1 (en) | 2015-02-25 | 2017-10-12 | Sun Pharma Advanced Research Company Ltd | Nanoparticulate composition |
| US9918998B2 (en) | 2015-03-23 | 2018-03-20 | BioPharmX, Inc. | Pharmaceutical tetracycline composition for dermatological use |
| EP3504554B1 (en) | 2016-08-23 | 2024-04-03 | University of Maryland, Baltimore | Methods for detecting and/or predicting age-related macular degeneration and/or alzheimer's disease |
| CA2978573A1 (en) | 2016-09-08 | 2018-03-08 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
| TR201910426A2 (en)* | 2019-07-12 | 2019-08-21 | Assos Ilac Kimya Gida Ueruenleri Ueretim Ve Ticaret Anonim Sirketi | STABILITY FORMULATION WITH TETRASYCLIN AND TRETINOIN FOR TOPICAL ACNE TREATMENT |
| CN112022809A (en)* | 2020-08-14 | 2020-12-04 | 河北远征药业有限公司 | A kind of oxytetracycline aerosol and preparation method thereof |
| CN111956612A (en)* | 2020-08-14 | 2020-11-20 | 河北远征药业有限公司 | Oxytetracycline spray and preparation method thereof |
| CN115554243B (en)* | 2022-11-11 | 2023-03-03 | 新基元(北京)医药科技有限公司 | Minocycline foam for treating acne rosacea |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3389174A (en) | 1962-10-04 | 1968-06-18 | American Cyanamid Co | Stable tetracycline solutions |
| US3219529A (en) | 1962-10-04 | 1965-11-23 | American Cyanamid Co | Stable tetracycline solutions |
| US4376118A (en) | 1980-10-06 | 1983-03-08 | Miles Laboratories, Inc. | Stable nonaqueous solution of tetracycline salt |
| US5122519A (en)* | 1989-06-27 | 1992-06-16 | American Cyanamid Company | Stable, cosmetically acceptable topical gel formulation and method of treatment for acne |
| WO2008097850A1 (en) | 2007-02-02 | 2008-08-14 | Warner Chilcott Company, Inc. | Tretracycline compositions for topical administration |
| WO2008097851A1 (en) | 2007-02-02 | 2008-08-14 | Warner Chilcott Company, Inc. | Tetracycline compositions for topical administration |
| WO2009090495A2 (en)* | 2007-12-07 | 2009-07-23 | Foamix Ltd. | Oil and liquid silicone foamable carriers and formulations |
| PT104644B (en)* | 2009-06-26 | 2012-11-06 | Hovione Farmaciencia S A | Topical formulation containing a tetracycline and a method of treating skin infections using the same |
| US8592380B2 (en)* | 2010-03-26 | 2013-11-26 | Precision Dermatology, Inc. | Aerosol foams comprising clindamycin phosphate |
| MX354137B (en)* | 2011-01-19 | 2018-02-14 | Laboratory Skin Care Inc | Topical minocycline compositions and methods of using the same. |
| Publication number | Publication date |
|---|---|
| US20160287614A1 (en) | 2016-10-06 |
| WO2015075640A1 (en) | 2015-05-28 |
| Publication | Publication Date | Title |
|---|---|---|
| IN2013MU03646A (en) | ||
| PH12019501321A1 (en) | Methods of treating or preventing cholesterol related disorders | |
| TN2015000519A1 (en) | Small molecule inhibitors of fibrosis | |
| PH12015502031A1 (en) | Tetrahydropyrrolothiazine compounds | |
| MX361499B (en) | Deuterated baricitinib. | |
| MX2015001246A (en) | Deuterated ibrutinib. | |
| HK1216083A1 (en) | Trans-arterial drug delivery | |
| EP3019166A4 (en) | A pharmaceutical combination for the treatment of melanoma | |
| PH12015501588A1 (en) | Compounds and methods for treating bacterial infections | |
| WO2014153495A3 (en) | Novel stat3 inhibitors | |
| CL2016001349A1 (en) | Use of benzimidazole-proline derivatives | |
| MX2015008829A (en) | Deuterated momelotinib. | |
| IN2013MU03862A (en) | ||
| NZ730816A (en) | Quinoline carboxamides for use in the treatment of multiple myeloma | |
| IN2013MU01985A (en) | ||
| NZ732704A (en) | Quinoline carboxamides for use in the treatment of leukemia | |
| HK1212978A1 (en) | Novel derivatives of sinapinic acid | |
| WO2014145314A3 (en) | Methods and compositions for gamma-glutamyl cycle modulation | |
| MX345263B (en) | Stable pexiganan formulation. | |
| EP3054996A4 (en) | High purity therapeutic bone agents | |
| MX2015012610A (en) | Deuterated pacritinib. | |
| MX2016005160A (en) | Pharmaceutical compositions comprising antibacterial agents. | |
| MX2016005539A (en) | Pharmaceutical compositions comprising antibacterial agents. | |
| NZ719215A (en) | Pharmaceutical compositions comprising antibacterial agents | |
| EP3024427A4 (en) | Derivatives of 2,2,6-trimethylcyclohexane-carboxylate |